within Pharmacolibrary.Drugs.ATC.J;

model J01CA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.55,
    Cl             = 7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Mecillinam is a beta-lactam antibiotic of the penicillin class, specifically an amidinopenicillin, used primarily to treat urinary tract infections caused by Gram-negative bacteria, particularly Escherichia coli. It is approved and is still in clinical use, especially in Scandinavia and some European countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral and intravenous administration; typical clinical dosing.</p><h4>References</h4><ol><li><p>Parsons, RL, et al., &amp; Paddock, GM (1977). Pharmacokinetics of pivmecillinam. <i>British journal of clinical pharmacology</i> 4(3) 267–273. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1977.tb00711.x&quot;>10.1111/j.1365-2125.1977.tb00711.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/197981/&quot;>https://pubmed.ncbi.nlm.nih.gov/197981</a></p></li><li><p>Zhang, LL, et al., &amp; Wang, YQ (2024). Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study. <i>Naunyn-Schmiedeberg&#x27;s archives of pharmacology</i> 397(10) 7639–7647. DOI:<a href=&quot;https://doi.org/10.1007/s00210-024-03118-3&quot;>10.1007/s00210-024-03118-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38691150/&quot;>https://pubmed.ncbi.nlm.nih.gov/38691150</a></p></li><li><p>Heikkilä, A, et al., &amp; Iisalo, E (1992). The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women. <i>British journal of clinical pharmacology</i> 33(6) 629–633. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1992.tb04092.x&quot;>10.1111/j.1365-2125.1992.tb04092.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1389936/&quot;>https://pubmed.ncbi.nlm.nih.gov/1389936</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA11;
